VBWG - Resource Item

Resources

Quick Order
About Create Profile Login
Email: Password:

Slide Lecture Programs
2003 Core Curriculum cash advance cash advance
Impact of vascular biology in treatment of cardiovascular disease Section III: Neurohormonal strategies in the failing heart cash advance cash advance
May 3, 2003
Table of Contents - 50 slides
No.	Title
1	Heart failure: US statistics cash advance cash advance
2	The comparative cost of heart failure cash advance cash advance
3	High lifetime risk of heart failure cash advance cash advance
4	Strategies to prevent/reverse HF progression cash advance cash advance
5	Role of RAAS and SNS in HF progression cash advance cash advance
6	Combination ACEI and ß-blockade enhances RAAS inhibition in patients with HF cash advance cash advance
7	ß-Blockade blunts stress-related increase in coronary atherosclerosis in monkeys cash advance cash advance
8	ß-Blocker Cholesterol-lowering Asymptomatic Plaque Study (BCAPS): Study design cash advance cash advance
9	BCAPS: Change in carotid artery bulb IMT during 3-year follow-up cash advance cash advance
10	ELVA: Study design cash advance cash advance
11	ELVA: ß-Blockade decreases atherosclerotic progression in carotid IMT composite cash advance cash advance
12	Results from Heart Protection Study: First major vascular event (coronary event, stroke, revascularization) - Interaction of statins with ß-blockers cash advance cash advance
13	Hypothesis: ß-Blockade improves myocardial function and reverses remodeling by altering cardiac myocyte gene expression cash advance cash advance
14	Myocardial gene expression in dilated cardiomyopathy in response to ß-blocker therapy cash advance cash advance
15	Hypothetical mechanism of ß-blocker induced improvement in myocardial function and reversal of remodeling cash advance cash advance
16	Potential consequences of inflammation in heart failure cash advance cash advance
17	Potential associations of early ß-blockade cash advance cash advance
18	Survival studies of ß-blockade in heart failure cash advance cash advance
19	MERIT-HF: Reduction in total mortality and hospitalizations in women receiving ß-blockade cash advance cash advance
20	MERIT-HF: Efficacy of ß-blockade in elderly patients with heart failure cash advance cash advance
21	COPERNICUS: Effect of ß-blockade in patients with severe HF by sex and age cash advance cash advance
22	MERIT-HF: Effects of ß-blockade on mortality in post-MI and hypertensive patient subgroups cash advance cash advance
23	MERIT-HF: Effect of ß-blockade on total mortality or HF hospitalization in diabetic and nondiabetic patients cash advance cash advance
24	ß-Blocker titration in major HF trials cash advance cash advance
25	MERIT HF: Discontinuation from study medicine during follow-up cash advance cash advance
26	MERIT-HF: Consistent heart rate reduction with lower vs higher ß-blocker dose cash advance cash advance
27	MERIT-HF: Flexible dosing achieves consistent results cash advance cash advance
28	ß-Blockade modifies circadian pattern of ventricular tachyarrhythmias cash advance cash advance
29	Sudden death: Risk reduction with ß-blockade cash advance cash advance
30	MADIT II: Survival with prophylactic ICD in MI patients with EF <30% cash advance cash advance
31	Predictive power of BNP for HF hospitalization or death cash advance cash advance
32	Treatment benefits of ß-blockade cash advance cash advance
33	ß-Blockade for cardioprotection cash advance cash advance
34	SOLVD: Effect of ß-blockade on mortality in patients with asymptomatic LV systolic dysfunction (post hoc analysis) cash advance cash advance
35	ACC/AHA heart failure guidelines: Treating asymptomatic patients cash advance cash advance
36	ACC/AHA heart failure guidelines: Treating symptomatic patients cash advance cash advance
37	Contemporary therapy for heart failure cash advance cash advance
38	Effect of ß-blockade on mortality among high-risk post-MI patient subgroups: Observational study cash advance cash advance
39	Potential role of ß-blockade in survival after percutaneous coronary intervention cash advance cash advance
40	ß-Blockade after percutaneous coronary intervention: Benefits observed in high-risk subgroups cash advance cash advance
41	Common misconceptions about ß-blockade cash advance cash advance
42	ß-Blockade and potential symptoms of depression, fatigue, and sexual dysfunction cash advance cash advance
43	Expanded options for patients with renal hypertension: AASK study design cash advance cash advance
44	AASK: Effect of drug intervention on proteinuria cash advance cash advance
45	AASK: Risk reduction in GFR decline, ESRD, or death-Outcomes with higher proteinuria cash advance cash advance
46	AASK: BP achieved vs drugs required cash advance cash advance
47	Trends in cardiac medications of proven benefit in outpatients cash advance cash advance
48	Secondary prevention medications are underprescribed in women with CAD cash advance cash advance
49	Morbidity and mortality benefits of ß-blockade in HF: Number needed-to-treat analysis cash advance cash advance
50	Health and economic impact of increased use of ß-blockers after first MI cash advance cash advance


Home \| Literature Update \| Journal Link \| Resources \| Meeting Highlights \| Members \| About VBWG \| Web Links